[TRIAL OF OXYPHENBUTAZONE, NEW ANTI-INFLAMMATORY TREATMENT OF PULMONARY AND PLEURAL TUBERCULOSIS].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D001772:Blood Cell Count; D001786:Blood Glucose; D001799:Blood Sedimentation; D004614:Emaciation; D005000:Ethionamide; D005334:Fever; D007538:Isoniazid; D009584:Nitrogen; D010113:Oxyphenbutazone; D010996:Pleural Effusion; D011516:Prothrombin; D013902:Radiography, Thoracic; D013307:Streptomycin; D014116:Toxicology; D014376:Tuberculosis; D014396:Tuberculosis, Pleural; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D001786:Blood Glucose; D010131:Aminosalicylic Acid; D011516:Prothrombin; D010113:Oxyphenbutazone; D009584:Nitrogen; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; BLOOD CELL COUNT; BLOOD SEDIMENTATION; BLOOD SUGAR; EMACIATION; ETHIONIAMIDE; FEVER; ISONIAZID; NITROGEN; OXYPHENBUTAZONE; PLEURAL EFFUSION; PROTHROMBIN; STREPTOMYCIN; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY
ESSAI DE L'OXYPHEN-BUTAZONE, NOUVEAU TRAITEMENT ANTI-INFLAMMATOIRE DES TUBERCULOSES PULMONAIRES ET PLEURALES.